Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: A systematic review and meta-analysis

OncoTargets and Therapy

Volumn 10, Issue , 2017, Pages 2885-2892

  Li, Ming ^a   Yang, Xiaodong ^a   Chen, Yuhan ^a   Yang, Xinyu ^a   Dai, Xiyu ^a   Sun, Fenghao ^a   Zhang, Li ^a   Zhan, Cheng ^a   Feng, Mingxiang ^a   Wang, Qun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Lobectomy; Meta analysis; Non small cell lung cancer; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy; Sublobectomy

Indexed keywords

ABLATION THERAPY; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; LUNG LOBECTOMY; META ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; WEDGE RESECTION;

EID: 85020469056     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S138701     Document Type: Article

References (24)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29.
2. Bertolaccini L, Terzi A, Ricchetti F, Alongi F. Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future? Ann Transl Med. 2015;3(2):25.
3. Khullar OV, Liu Y, Gillespie T, et al. Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: an analysis from the National Cancer Data Base. J Thorac Oncol. 2015;10(11): 1625-1633.
4. Boily G, Filion É, Rakovich G, et al; Comité de l’évolution des pratiques en oncologie. Stereotactic ablative radiation therapy for the treatment of early-stage non-small-cell lung cancer: CEPO review and recommendations. J Thorac Oncol. 2015;10(6):872-882.
5. Crabtree TD, Puri V, Robinson C, et al. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. J Thorac Cardiovasc Surg. 2014;147(4):1183-1191; discussion 1191-1192.
6. Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol. 2013; 24(6):1543-1548.
7. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S. Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol. 2011;101(2):240-244.
8. Vansteenkiste J, Crinò L, Dooms C, et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8): 1462-1474.
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
10. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
11. Rosen JE, Salazar MC, Wang Z, et al. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016;152(1):44-54.e9.
12. Wang P, Zhang D, Guo XG, et al. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly. Medicine (Baltimore). 2016;95(52):e5723.
13. Ezer N, Veluswamy RR, Mhango G, Rosenzweig KE, Powell CA, Wisnivesky JP. Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer. J Thorac Oncol. 2015;10(8):1201-1206.
14. Hamaji M, Chen F, Matsuo Y, et al. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015;99(4):1122-1129.
15. van den Berg LL, Klinkenberg TJ, Groen HJ, Widder J. Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC. J Thorac Oncol. 2015;10(5):826-831.
16. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol. 2015;16(6): 630-637.
17. Kastelijn EA, El Sharouni SY, Hofman FN, et al. Clinical outcomes in early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection. Anticancer Res. 2015;35(10):5607-5614.
18. Nakagawa T, Negoro Y, Matsuoka T, Okumura N, Dodo Y. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer. Respir Investig. 2014;52(4):221-226.
19. Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis. Eur J Cancer. 2014; 50(17):2932-2938.
20. Port JL, Parashar B, Osakwe N, et al. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer. Ann Thorac Surg. 2014;98(4):1152-1159.
21. Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I nonsmall cell lung cancer treated with resection or stereotactic radiosurgery. Cancer. 2013;119(15):2683-2691.
22. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28(6):928-935.
23. Shen Y, Wang H, Feng M, Xi Y, Tan L, Wang Q. Single-versus multipleport thoracoscopic lobectomy for lung cancer: a propensity-matched study†. Eur J Cardiothorac Surg. 2016;49(Suppl 1):i48-i53.
24. Lin Z, Xi J, Xu S, Jiang W, Wang L, Wang Q. Uniportal video-assisted thoracic surgery lobectomy in semiprone position: primary experience of 105 cases. J Thorac Dis. 2015;7(12):2389-2395.